These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
307 related articles for article (PubMed ID: 30479372)
21. Glutaminase 2 negatively regulates the PI3K/AKT signaling and shows tumor suppression activity in human hepatocellular carcinoma. Liu J; Zhang C; Lin M; Zhu W; Liang Y; Hong X; Zhao Y; Young KH; Hu W; Feng Z Oncotarget; 2014 May; 5(9):2635-47. PubMed ID: 24797434 [TBL] [Abstract][Full Text] [Related]
22. HS-116, a novel phosphatidylinositol 3-kinase inhibitor induces apoptosis and suppresses angiogenesis of hepatocellular carcinoma through inhibition of the PI3K/AKT/mTOR pathway. Jung KH; Choi MJ; Hong S; Lee H; Hong SW; Zheng HM; Lee HS; Hong S; Hong SS Cancer Lett; 2012 Mar; 316(2):187-95. PubMed ID: 22182943 [TBL] [Abstract][Full Text] [Related]
23. ADAM17 mediates hypoxia-induced drug resistance in hepatocellular carcinoma cells through activation of EGFR/PI3K/Akt pathway. Wang XJ; Feng CW; Li M Mol Cell Biochem; 2013 Aug; 380(1-2):57-66. PubMed ID: 23625205 [TBL] [Abstract][Full Text] [Related]
24. An ethyl acetate fraction of Artemisia capillaris (ACE-63) induced apoptosis and anti-angiogenesis via inhibition of PI3K/AKT signaling in hepatocellular carcinoma. Jung KH; Rumman M; Yan H; Cheon MJ; Choi JG; Jin X; Park S; Oh MS; Hong SS Phytother Res; 2018 Oct; 32(10):2034-2046. PubMed ID: 29972254 [TBL] [Abstract][Full Text] [Related]
25. HIPK2 suppresses tumor growth and progression of hepatocellular carcinoma through promoting the degradation of HIF-1α. Chen P; Duan X; Li X; Li J; Ba Q; Wang H Oncogene; 2020 Apr; 39(14):2863-2876. PubMed ID: 32034309 [TBL] [Abstract][Full Text] [Related]
26. Loss of Mel-18 induces tumor angiogenesis through enhancing the activity and expression of HIF-1α mediated by the PTEN/PI3K/Akt pathway. Park JH; Lee JY; Shin DH; Jang KS; Kim HJ; Kong G Oncogene; 2011 Nov; 30(45):4578-89. PubMed ID: 21602890 [TBL] [Abstract][Full Text] [Related]
27. Activation of PI3 kinase/Akt/HIF-1α pathway contributes to hypoxia-induced epithelial-mesenchymal transition and chemoresistance in hepatocellular carcinoma. Jiao M; Nan KJ Int J Oncol; 2012 Feb; 40(2):461-8. PubMed ID: 21922131 [TBL] [Abstract][Full Text] [Related]
29. Magnolol suppresses hypoxia-induced angiogenesis via inhibition of HIF-1α/VEGF signaling pathway in human bladder cancer cells. Chen MC; Lee CF; Huang WH; Chou TC Biochem Pharmacol; 2013 May; 85(9):1278-87. PubMed ID: 23416116 [TBL] [Abstract][Full Text] [Related]
30. Bufalin suppresses hepatocellular carcinoma invasion and metastasis by targeting HIF-1α via the PI3K/AKT/mTOR pathway. Wang H; Zhang C; Xu L; Zang K; Ning Z; Jiang F; Chi H; Zhu X; Meng Z Oncotarget; 2016 Apr; 7(15):20193-208. PubMed ID: 26958938 [TBL] [Abstract][Full Text] [Related]
31. Sprengerinin C exerts anti-tumorigenic effects in hepatocellular carcinoma via inhibition of proliferation and angiogenesis and induction of apoptosis. Zeng KW; Li N; Dong X; Ma ZZ; Jiang Y; Jin HW; Tu PF Eur J Pharmacol; 2013 Aug; 714(1-3):261-73. PubMed ID: 23684542 [TBL] [Abstract][Full Text] [Related]
32. Sorafenib inhibits hypoxia-inducible factor-1α synthesis: implications for antiangiogenic activity in hepatocellular carcinoma. Liu LP; Ho RL; Chen GG; Lai PB Clin Cancer Res; 2012 Oct; 18(20):5662-71. PubMed ID: 22929805 [TBL] [Abstract][Full Text] [Related]
33. A positive feedback loop between ROS and Mxi1-0 promotes hypoxia-induced VEGF expression in human hepatocellular carcinoma cells. Hu Z; Dong N; Lu D; Jiang X; Xu J; Wu Z; Zheng D; Wechsler DS Cell Signal; 2017 Feb; 31():79-86. PubMed ID: 28065785 [TBL] [Abstract][Full Text] [Related]
34. MiR-497 suppresses angiogenesis and metastasis of hepatocellular carcinoma by inhibiting VEGFA and AEG-1. Yan JJ; Zhang YN; Liao JZ; Ke KP; Chang Y; Li PY; Wang M; Lin JS; He XX Oncotarget; 2015 Oct; 6(30):29527-42. PubMed ID: 26336827 [TBL] [Abstract][Full Text] [Related]
35. Sorcin promotes proliferation of hepatocellular carcinoma by regulating VEGFA/B via PI3K pathway. Zhang H; Hu S; Sanches JGP; Li Y; Wei Y; Pu C; Zhang J J Physiol Biochem; 2024 May; 80(2):381-392. PubMed ID: 38536659 [TBL] [Abstract][Full Text] [Related]
36. Combined Treatment of Tanshinone I and Epirubicin Revealed Enhanced Inhibition of Hepatocellular Carcinoma by Targeting PI3K/AKT/HIF-1α. Zhao J; Lin E; Cai C; Zhang M; Li D; Cai S; Zeng G; Yin Z; Wang B; Li P; Hong X; Chen J; Zou B; Li J Drug Des Devel Ther; 2022; 16():3197-3213. PubMed ID: 36158238 [TBL] [Abstract][Full Text] [Related]
37. Sorafenib blocks the activation of the HIF-2α/VEGFA/EphA2 pathway, and inhibits the rapid growth of residual liver cancer following high-intensity focused ultrasound therapy in vivo. Wu L; Zhou J; Zhou W; Huang XF; Chen Q; Wang W; Zhai L; Li S; Tang Z Pathol Res Pract; 2021 Apr; 220():153270. PubMed ID: 33640712 [TBL] [Abstract][Full Text] [Related]
38. CADM2, as a new target of miR-10b, promotes tumor metastasis through FAK/AKT pathway in hepatocellular carcinoma. Li D; Zhang Y; Zhang H; Zhan C; Li X; Ba T; Qiu Z; E F; Lv G; Zou C; Wang C; Si L; Zou C; Li Q; Gao X J Exp Clin Cancer Res; 2018 Mar; 37(1):46. PubMed ID: 29506532 [TBL] [Abstract][Full Text] [Related]
39. Regulation of angiogenesis by Id-1 through hypoxia-inducible factor-1alpha-mediated vascular endothelial growth factor up-regulation in hepatocellular carcinoma. Lee TK; Poon RT; Yuen AP; Ling MT; Wang XH; Wong YC; Guan XY; Man K; Tang ZY; Fan ST Clin Cancer Res; 2006 Dec; 12(23):6910-9. PubMed ID: 17145808 [TBL] [Abstract][Full Text] [Related]
40. Celecoxib Down-Regulates the Hypoxia-Induced Expression of HIF-1α and VEGF Through the PI3K/AKT Pathway in Retinal Pigment Epithelial Cells. Sun YZ; Cai N; Liu NN Cell Physiol Biochem; 2017; 44(4):1640-1650. PubMed ID: 29216640 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]